Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: A0A3S7WTT4
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 154 | 158 | PF00656 | 0.515 |
CLV_NRD_NRD_1 | 230 | 232 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.592 |
CLV_NRD_NRD_1 | 53 | 55 | PF00675 | 0.513 |
CLV_PCSK_FUR_1 | 228 | 232 | PF00082 | 0.477 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.423 |
CLV_PCSK_KEX2_1 | 230 | 232 | PF00082 | 0.503 |
CLV_PCSK_KEX2_1 | 282 | 284 | PF00082 | 0.490 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 53 | 55 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 2 | 4 | PF00082 | 0.423 |
CLV_PCSK_PC1ET2_1 | 282 | 284 | PF00082 | 0.487 |
CLV_PCSK_PC7_1 | 40 | 46 | PF00082 | 0.445 |
CLV_Separin_Metazoa | 236 | 240 | PF03568 | 0.517 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.418 |
DEG_SCF_FBW7_1 | 159 | 165 | PF00400 | 0.471 |
DOC_CKS1_1 | 159 | 164 | PF01111 | 0.492 |
DOC_CKS1_1 | 9 | 14 | PF01111 | 0.408 |
DOC_CYCLIN_yCln2_LP_2 | 9 | 15 | PF00134 | 0.401 |
DOC_MAPK_gen_1 | 50 | 59 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 269 | 276 | PF00069 | 0.328 |
DOC_MAPK_MEF2A_6 | 53 | 61 | PF00069 | 0.393 |
DOC_MAPK_NFAT4_5 | 54 | 62 | PF00069 | 0.479 |
DOC_SPAK_OSR1_1 | 269 | 273 | PF12202 | 0.427 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.587 |
DOC_USP7_MATH_1 | 293 | 297 | PF00917 | 0.656 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.507 |
DOC_WW_Pin1_4 | 174 | 179 | PF00397 | 0.773 |
DOC_WW_Pin1_4 | 242 | 247 | PF00397 | 0.643 |
DOC_WW_Pin1_4 | 296 | 301 | PF00397 | 0.748 |
DOC_WW_Pin1_4 | 34 | 39 | PF00397 | 0.542 |
DOC_WW_Pin1_4 | 8 | 13 | PF00397 | 0.465 |
LIG_14-3-3_CanoR_1 | 100 | 110 | PF00244 | 0.512 |
LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.373 |
LIG_14-3-3_CanoR_1 | 283 | 292 | PF00244 | 0.530 |
LIG_14-3-3_CanoR_1 | 3 | 12 | PF00244 | 0.425 |
LIG_BRCT_BRCA1_1 | 264 | 268 | PF00533 | 0.533 |
LIG_FHA_1 | 139 | 145 | PF00498 | 0.339 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.443 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.534 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.475 |
LIG_FHA_2 | 67 | 73 | PF00498 | 0.407 |
LIG_FHA_2 | 9 | 15 | PF00498 | 0.563 |
LIG_LIR_Gen_1 | 68 | 78 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 68 | 74 | PF02991 | 0.427 |
LIG_PDZ_Class_1 | 299 | 304 | PF00595 | 0.604 |
LIG_SH2_STAP1 | 280 | 284 | PF00017 | 0.436 |
LIG_SH2_STAP1 | 92 | 96 | PF00017 | 0.449 |
LIG_SH2_STAT5 | 285 | 288 | PF00017 | 0.398 |
LIG_SH3_3 | 156 | 162 | PF00018 | 0.569 |
LIG_SH3_3 | 289 | 295 | PF00018 | 0.683 |
LIG_SH3_3 | 35 | 41 | PF00018 | 0.506 |
LIG_WW_2 | 292 | 295 | PF00397 | 0.510 |
MOD_CDC14_SPxK_1 | 37 | 40 | PF00782 | 0.439 |
MOD_CDK_SPxK_1 | 34 | 40 | PF00069 | 0.486 |
MOD_CK1_1 | 176 | 182 | PF00069 | 0.671 |
MOD_CK1_1 | 296 | 302 | PF00069 | 0.625 |
MOD_CK1_1 | 33 | 39 | PF00069 | 0.552 |
MOD_CK2_1 | 66 | 72 | PF00069 | 0.415 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.493 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.436 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.474 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.382 |
MOD_GlcNHglycan | 217 | 220 | PF01048 | 0.507 |
MOD_GlcNHglycan | 264 | 267 | PF01048 | 0.568 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.622 |
MOD_GlcNHglycan | 295 | 298 | PF01048 | 0.628 |
MOD_GlcNHglycan | 32 | 35 | PF01048 | 0.693 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.526 |
MOD_GSK3_1 | 168 | 175 | PF00069 | 0.600 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.729 |
MOD_GSK3_1 | 295 | 302 | PF00069 | 0.697 |
MOD_GSK3_1 | 30 | 37 | PF00069 | 0.590 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.376 |
MOD_NEK2_1 | 151 | 156 | PF00069 | 0.380 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.476 |
MOD_PKB_1 | 98 | 106 | PF00069 | 0.363 |
MOD_Plk_1 | 65 | 71 | PF00069 | 0.428 |
MOD_Plk_2-3 | 66 | 72 | PF00069 | 0.377 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.476 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.370 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.446 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.507 |
MOD_ProDKin_1 | 174 | 180 | PF00069 | 0.772 |
MOD_ProDKin_1 | 242 | 248 | PF00069 | 0.644 |
MOD_ProDKin_1 | 296 | 302 | PF00069 | 0.748 |
MOD_ProDKin_1 | 34 | 40 | PF00069 | 0.540 |
MOD_ProDKin_1 | 8 | 14 | PF00069 | 0.465 |
TRG_DiLeu_BaLyEn_6 | 76 | 81 | PF01217 | 0.409 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.446 |
TRG_ER_diArg_1 | 228 | 231 | PF00400 | 0.515 |
TRG_ER_diArg_1 | 43 | 46 | PF00400 | 0.519 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ILL8 | Leptomonas seymouri | 52% | 90% |
A0A3R7RI28 | Trypanosoma rangeli | 33% | 100% |
A4H8A3 | Leishmania braziliensis | 75% | 100% |
A4HWM3 | Leishmania infantum | 100% | 100% |
C9ZXR4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AQD0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
Q4QF45 | Leishmania major | 91% | 100% |